secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncology Institute, Inc. (TOI)
CIK:        0001799191
Form:       8-K
Filed at:   2022-03-07T23:59:59+00:00
Accession:  0001628280-22-005246
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TOI promotes Dr. Daniel Virnich to President and Dr. Matthew Miller to COO
--------------------------------------------------------------------------

- Dr. Daniel Virnich promoted from COO to President, effective March 15, 2022.
- Dr. Matthew Miller promoted from Chief Administrative Officer to COO, effective same date.
- Board approved RSU/option grants: CEO Hively $678K RSU + $1.38M options; Virnich $263K RSU + $533K options; Dalgleish $201K RSU + $407K options.
- Updated 2021 compensation: Hively $11.6M, Virnich $7.6M, Dalgleish $4.8M total pay.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799191/000162828022005246/0001628280-22-005246-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799191/000162828022005246/toi-20220302.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-005246

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer